Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
crispr
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
alphabet
andrew oxtoby
babies
boulder/denver blog main
boulder/denver top stories
breakup
bridge bio pharma
broad institute of harvard and mit
brook byers
ceo
charles chu
clinical hold
clinical study
combination
commissioner
congress
crispr cas14
crispr-cas9
deals
decheng capital
delisting
democrats
departure
detroit blog main
detroit top stories
diagnostic
drug pricing
What
big
2
×
bio
cas
2
×
crispr
available
based
biosciences
bosley's
bosley’s
bridge
bucks
ceo
cheaper
crime
departure
develop
diagnostics
editas
exit
expects
faster
guiding
katrine
mammoth
medicine
moves
personnel
roundup
set
surprising
things
tiny
today
week
what’s
Language
unset
Current search:
cas
×
big
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
